Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Wen Fang
- Phone Number: 19705094680
- Email: wenfang@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310009
- Recruiting
- The Second Affiliated Hospital Zhejiang University School of Medicine
-
Contact:
- Wen Fang
- Phone Number: 19705094680
- Email: wenfang@zju.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients undergoing liver transplantation or living donor hepatectomy at the study center (living donor should be approved by the hospital ethics committee for living organ donation);
- Age 18 years or older;
- Willing to participate in the long-term follow-up management program;
- Signed informed consent form;
Exclusion Criteria:
- Patients undergoing combined organ transplantation
- Patients with severe mental illness or cognitive impairment who are unable to cooperate with follow-up assessments.
- Donors whose surgery is aborted intraoperatively for any reason.
- Unable or unwilling to comply with the long-term follow-up schedule.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
recipients
A patient who received a new, healthy liver (or part of one from a living donor) to replace their own diseased liver
|
Patients undergo standard liver transplantation according to clinical protocols.
Postoperative management and follow-up are conducted per routine standard of care.
Clinical data, including survival, adverse events, and quality of life (assessed by questionnaires/scales), are collected observationally at regular follow-up intervals.
|
|
living donors
A healthy person who donated a portion of their healthy liver to someone with liver failure.
|
Living donors undergo standard hepatectomy procedures.
Postoperative recovery and long-term health outcomes are monitored through routine follow-up visits and assessments.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Long-term Incidence of Postoperative Adverse Events
Time Frame: From date of surgery up to 20 years
|
Evaluation of the cumulative incidence of postoperative complications
|
From date of surgery up to 20 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Survival
Time Frame: Up to 20 years
|
Up to 20 years
|
|
|
Graft Survival Rate
Time Frame: Up to 20 years
|
Up to 20 years
|
|
|
Patient-Reported Outcome questionnaire
Time Frame: Baseline and annually up to 20 years
|
Assessment of multiple dimensions of patient health status, including physical functioning, mental health, social well-being, symptoms burden (e.g., pain, fatigue), and medication adherence.
These domains will be evaluated using a battery of standard validated instruments
|
Baseline and annually up to 20 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Wen Fang, Second Affiliated Hospital, School of Medicine, Zhejiang University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2025-0793
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.